FluoroPharma Medical (FPMI) Guided By Industry Leaders
FluoroPharma develops and commercializes proprietary medical diagnostic imaging products for use with positron emission tomography (PET). The company’s current focus is on the detection and assessment of acute and chronic forms of coronary artery disease (CAD), in addition to the detection of inflamed atherosclerotic plaque in peripheral arteries, and amyloid plaque in Alzheimer’s disease. Leading FluoroPharma’s development are its key executives:
• Thijs Spoor (Chairman & CEO) – Mr. Spoor previously held the title of CFO for Sunstone BioSciences. He holds a Nuclear Pharmacy degree from the University of Toronto as well as an M.B.A. from Columbia University with concentrations in finance and accounting. Mr. Spoor has been a guest lecturer at Columbia Business School, Kings College in London, and the University of Newcastle in Australia and has presented at medical grand rounds and psychiatric grand rounds at various hospitals on the role of brain imaging. Prior to joining Sunstone BioSciences, Mr. Spoor worked as a consultant at Oliver Wyman, focusing on helping pharmaceutical and medical device companies evaluate their global revenue potential given the complex interplay of regulatory approvals, the reimbursement environment, as well as the impact of physician preference within constantly evolving standards of care. He further specialized on the implications of healthcare reform on new product approval and health insurance reform.
• Boyan Goumnerov, MD (COO & VP Clinical Trials) – Prior to his appointment with FluoroPharma Dr. Goumnerov held executive positions in the healthcare and biomedical research fields, most recently as President of VasoStent, Inc. and managing director of CardioVas Inc.- start-up medical device companies targeting the field of intravascular cardiac imaging and therapy. His academic background includes research within the departments of Surgery and Molecular Biology at the Massachusetts General Hospital (MGH) and The Shriners Burn Hospital for Children, Boston, where he held academic appointments with Harvard Medical School. Dr. Goumnerov also did extensive work within the Department of Pathology/Neuropathology at Children’s Hospital Boston, in developing image analysis protocols for evaluation of neuromuscular diseases before moving to MGH. He is co-author of numerous scientific publications. Dr. Goumnerov obtained his M.D. from the Medical University of Sofia, Bulgaria, and worked as a clinician prior to relocating to the US.
• Tamara Rhein (CFO) – Ms. Rhein joined FluoroPharma in 2011 as Controller. Prior to FluoroPharma, she was Controller of Manhattan Pharmaceuticals, where, in addition to maintaining the critical financial functions for the company, she was also responsible for a wide range of activities including financial statement preparation, footnote disclosures for SEC filings, stock option accounting, and quarterly and year-end audits. Before Manhattan Pharmaceuticals, Ms. Rhein was with Vyteris, where her primary role was to manage the SEC accounting and reporting department. In addition to her financial responsibilities, Ms. Rhein worked with the CEO on the launch of a new product. In this capacity, she managed critical aspects of coordination, timing and tracking of the initiative. Before joining Vyteris, Ms. Rhein was Vice President of New Business at Credit Suisse First Boston, where she provided comprehensive research and analysis to guide Senior Management on certain projects and complex business transactions.
For more information, see the company website at www.FluoroPharma.com
FluoroPharma Medical (FPMI) Guided By Industry Leaders
FluoroPharma develops and commercializes proprietary medical diagnostic imaging products for use with positron emission tomography (PET). The company’s current focus is on the detection and assessment of acute and chronic forms of coronary artery disease (CAD), in addition to the detection of inflamed atherosclerotic plaque in peripheral arteries, and amyloid plaque in Alzheimer’s disease. Leading FluoroPharma’s development are its key executives:
• Thijs Spoor (Chairman & CEO) – Mr. Spoor previously held the title of CFO for Sunstone BioSciences. He holds a Nuclear Pharmacy degree from the University of Toronto as well as an M.B.A. from Columbia University with concentrations in finance and accounting. Mr. Spoor has been a guest lecturer at Columbia Business School, Kings College in London, and the University of Newcastle in Australia and has presented at medical grand rounds and psychiatric grand rounds at various hospitals on the role of brain imaging. Prior to joining Sunstone BioSciences, Mr. Spoor worked as a consultant at Oliver Wyman, focusing on helping pharmaceutical and medical device companies evaluate their global revenue potential given the complex interplay of regulatory approvals, the reimbursement environment, as well as the impact of physician preference within constantly evolving standards of care. He further specialized on the implications of healthcare reform on new product approval and health insurance reform.
• Boyan Goumnerov, MD (COO & VP Clinical Trials) – Prior to his appointment with FluoroPharma Dr. Goumnerov held executive positions in the healthcare and biomedical research fields, most recently as President of VasoStent, Inc. and managing director of CardioVas Inc.- start-up medical device companies targeting the field of intravascular cardiac imaging and therapy. His academic background includes research within the departments of Surgery and Molecular Biology at the Massachusetts General Hospital (MGH) and The Shriners Burn Hospital for Children, Boston, where he held academic appointments with Harvard Medical School. Dr. Goumnerov also did extensive work within the Department of Pathology/Neuropathology at Children’s Hospital Boston, in developing image analysis protocols for evaluation of neuromuscular diseases before moving to MGH. He is co-author of numerous scientific publications. Dr. Goumnerov obtained his M.D. from the Medical University of Sofia, Bulgaria, and worked as a clinician prior to relocating to the US.
• Tamara Rhein (CFO) – Ms. Rhein joined FluoroPharma in 2011 as Controller. Prior to FluoroPharma, she was Controller of Manhattan Pharmaceuticals, where, in addition to maintaining the critical financial functions for the company, she was also responsible for a wide range of activities including financial statement preparation, footnote disclosures for SEC filings, stock option accounting, and quarterly and year-end audits. Before Manhattan Pharmaceuticals, Ms. Rhein was with Vyteris, where her primary role was to manage the SEC accounting and reporting department. In addition to her financial responsibilities, Ms. Rhein worked with the CEO on the launch of a new product. In this capacity, she managed critical aspects of coordination, timing and tracking of the initiative. Before joining Vyteris, Ms. Rhein was Vice President of New Business at Credit Suisse First Boston, where she provided comprehensive research and analysis to guide Senior Management on certain projects and complex business transactions.
For more information, see the company website at www.FluoroPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, May 31, 2013
Capstone Turbine Corp. (CPST) Receives Order from Nation’s Largest Natural Gas Distribution Utility to Provide Hybrid UPS for Green Data Center
Capstone Turbine, the world’s leading clean technology manufacturer of microturbine energy systems, received an order from California Gas Company (SoCalGas), the nation’s largest natural gas utility, for three patented C65 Hybrid Uninterruptible Power Source (Hybrid UPS) to be installed at the company’s data center.
The world’s first UPS system that integrates low-emission microturbines directly with a dual-conversion UPS, Capstone’s Hybrid UPS provides low-emission and highly reliable power for mission-critical loads.
Regatta Solutions, Inc., Capstone’s Southern California distributor, secured the order that features several Hybrid UPS microturbines deployed for critical load application. The Hybrid UPS provides an alternative to traditional UPS solutions and can easily integrate with an absorption chiller to create a combined cooling, heating, and power (CCHP) system which provides IT-grade power (eight 9′s reliability), facility heat, and chilled water for space cooling.
SoCalGas’s data center, located in Monterey Park, California, will be outfitted with Capstone Hybrid UPS microturbine units and an advanced double-effect Thermax exhaust-fired absorption chiller. The turbines will generate clean-and-green power onsite that will support critical loads. The microturbines will utilize clean waste-heat energy to drive the absorption chiller to meet the data center’s cooling needs in the summer and support heating needs in the winter.
SoCalGas operates in more than 500 Southern California communities, providing safe and reliable energy to 20.9 million consumers. The company’s services a territory that encompasses approximately 20,000 square miles.
“When used in a UPS application, the Capstone Hybrid UPS units emit ultra-low greenhouse-gas emissions and do not produce hazardous materials common with traditional battery-based UPS systems, which makes them the optimal clean-and-green power system for SoCalGas,” commented Darren Jamison, Capstone’s President and Chief Executive Officer.
“Since its market introduction in 2008, Capstone’s Hybrid UPS has proven to be a key component of green, energy-efficient data centers,” stated Jim Crouse, Capstone’s Executive Vice President, Sales and Marketing. “In addition to its reliability and economic benefits, Capstone’s Hybrid UPS can be used in a CCHP application, making it extremely efficient.”
For more information on Capstone Turbine Corporation, please visit www.capstoneturbine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The world’s first UPS system that integrates low-emission microturbines directly with a dual-conversion UPS, Capstone’s Hybrid UPS provides low-emission and highly reliable power for mission-critical loads.
Regatta Solutions, Inc., Capstone’s Southern California distributor, secured the order that features several Hybrid UPS microturbines deployed for critical load application. The Hybrid UPS provides an alternative to traditional UPS solutions and can easily integrate with an absorption chiller to create a combined cooling, heating, and power (CCHP) system which provides IT-grade power (eight 9′s reliability), facility heat, and chilled water for space cooling.
SoCalGas’s data center, located in Monterey Park, California, will be outfitted with Capstone Hybrid UPS microturbine units and an advanced double-effect Thermax exhaust-fired absorption chiller. The turbines will generate clean-and-green power onsite that will support critical loads. The microturbines will utilize clean waste-heat energy to drive the absorption chiller to meet the data center’s cooling needs in the summer and support heating needs in the winter.
SoCalGas operates in more than 500 Southern California communities, providing safe and reliable energy to 20.9 million consumers. The company’s services a territory that encompasses approximately 20,000 square miles.
“When used in a UPS application, the Capstone Hybrid UPS units emit ultra-low greenhouse-gas emissions and do not produce hazardous materials common with traditional battery-based UPS systems, which makes them the optimal clean-and-green power system for SoCalGas,” commented Darren Jamison, Capstone’s President and Chief Executive Officer.
“Since its market introduction in 2008, Capstone’s Hybrid UPS has proven to be a key component of green, energy-efficient data centers,” stated Jim Crouse, Capstone’s Executive Vice President, Sales and Marketing. “In addition to its reliability and economic benefits, Capstone’s Hybrid UPS can be used in a CCHP application, making it extremely efficient.”
For more information on Capstone Turbine Corporation, please visit www.capstoneturbine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cover-All Technologies, Inc. (COVR) BlueWave Claims Application Profiled in Celent Report
Cover-All Technologies, a Delaware Corporation, has announced that its BlueWave Claims application was recently profiled in “Claim System Vendors: North America P/C Insurance 2013,” which was published by Boston-based research and advisory firm Celent.
“We are very pleased to be included in this report,” said Cover-All President Manish Shah. “We believe inclusion in this Celent report reinforces BlueWave Claims as a smart choice for insurance carriers looking to modernize legacy claim systems.”
A rules and tools-based Web application, BlueWave Claims combines traditional claims administration with business process management (BPM). The solution features an intuitive, browser-based user interface (UI) on a flexible, scalable technology platform that enables seamless integration with existing in-house systems – all from a claims-centered point of view. The solution’s configurable workflows allow insurers to automate processes and change business rules without the need for added investment in professional services.
The Celent profile features: an overview of Cover-All’s background; product highlights; information about BlueWave Claims’ basic and enhanced functionality; product breadth; details about technology, usability, reporting, analytics, implementation timeframes and costs; and positive customer reviews regarding the implementation and the product.
“BlueWave Claims represents an important addition to Cover-All’s product portfolio,” the report stated. “The ongoing integration with Cover-All’s business intelligence offering will provide significant BI and analytic capabilities to insurers. BlueWave provides a good range of claim system functionality.”
BlueWave Claims was acquired by Cover-All in 2012, and it completes the company’s suite offering for the property/casualty P&C insurance market. Also included in this suite are Cover-All Policy, Cover-All Insurance Products (fully built-out ISO Commercial insurance products and Workers Compensation) and Cover-All Business Intelligence. Built on the most current technology combined with the power of Cover-All Studio products for self-configuration, conversion, and automated testing, these products allow customers to leverage technology for business results on their own terms – resulting in a solution that provides an easy-to-use, intuitive, and modern insurance suite building on Cover-All’s insurance expertise (particularly in ISO lines).
For more information, visit www.cover-all.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are very pleased to be included in this report,” said Cover-All President Manish Shah. “We believe inclusion in this Celent report reinforces BlueWave Claims as a smart choice for insurance carriers looking to modernize legacy claim systems.”
A rules and tools-based Web application, BlueWave Claims combines traditional claims administration with business process management (BPM). The solution features an intuitive, browser-based user interface (UI) on a flexible, scalable technology platform that enables seamless integration with existing in-house systems – all from a claims-centered point of view. The solution’s configurable workflows allow insurers to automate processes and change business rules without the need for added investment in professional services.
The Celent profile features: an overview of Cover-All’s background; product highlights; information about BlueWave Claims’ basic and enhanced functionality; product breadth; details about technology, usability, reporting, analytics, implementation timeframes and costs; and positive customer reviews regarding the implementation and the product.
“BlueWave Claims represents an important addition to Cover-All’s product portfolio,” the report stated. “The ongoing integration with Cover-All’s business intelligence offering will provide significant BI and analytic capabilities to insurers. BlueWave provides a good range of claim system functionality.”
BlueWave Claims was acquired by Cover-All in 2012, and it completes the company’s suite offering for the property/casualty P&C insurance market. Also included in this suite are Cover-All Policy, Cover-All Insurance Products (fully built-out ISO Commercial insurance products and Workers Compensation) and Cover-All Business Intelligence. Built on the most current technology combined with the power of Cover-All Studio products for self-configuration, conversion, and automated testing, these products allow customers to leverage technology for business results on their own terms – resulting in a solution that provides an easy-to-use, intuitive, and modern insurance suite building on Cover-All’s insurance expertise (particularly in ISO lines).
For more information, visit www.cover-all.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
VistaGen Therapeutics, Inc. (VSTA) and the Small Molecule
In the challenging world of drug development and production, one of the first factors to be considered is whether a drug will be a small molecule or big molecule drug. Big molecule drugs are often called simply biologics, although other terms are sometimes used for certain types of big molecule drugs. They are therapeutic drugs produced using biological processes, engineered from a living organism, and can be made up of complex proteins, nucleic acids, or even living cells. They’re useful in treating certain types of problems, but also have significant limitations, such as the fact that they can almost never be taken orally. In addition, they can be difficult to manufacture, which in turn can make them very expensive.
Small molecule drugs, on the other hand, can be chemically synthesized and are far easier to produce in volume. Small molecule drugs are the most common type of drug produced, and represent the heart of today’s pharmaceutical industry. Nevertheless, it can still be extremely expensive to research, develop, test, and market a brand new small-molecule drug. And, because small molecule drugs are such big business, anything that can help improve this process has enormous potential.
VistaGen Therapeutics is a California-based biotech company focused primarily on the use of its proprietary stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. This process generates new chemical variants of once-promising small molecule drug candidates that pharmaceutical companies have put on hold during preclinical or early clinical trials due to heart or liver toxicity, which is to say that the drugs were effective but had some toxic side effects. Using pluripotent stem cells as the base for their Human Clinical Trials in a Test Tube bioassay platform, VistaGen is able to more efficiently and cost effectively test for toxicity, allowing such drugs to be economically modified and rescued from the shelf.
For additional information, visit the company’s website at www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Small molecule drugs, on the other hand, can be chemically synthesized and are far easier to produce in volume. Small molecule drugs are the most common type of drug produced, and represent the heart of today’s pharmaceutical industry. Nevertheless, it can still be extremely expensive to research, develop, test, and market a brand new small-molecule drug. And, because small molecule drugs are such big business, anything that can help improve this process has enormous potential.
VistaGen Therapeutics is a California-based biotech company focused primarily on the use of its proprietary stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. This process generates new chemical variants of once-promising small molecule drug candidates that pharmaceutical companies have put on hold during preclinical or early clinical trials due to heart or liver toxicity, which is to say that the drugs were effective but had some toxic side effects. Using pluripotent stem cells as the base for their Human Clinical Trials in a Test Tube bioassay platform, VistaGen is able to more efficiently and cost effectively test for toxicity, allowing such drugs to be economically modified and rescued from the shelf.
For additional information, visit the company’s website at www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, May 30, 2013
Immunomedics, Inc. (IMMU) Provides Update on Antibody-Drug Conjugate Programs at New York Biotechnology Association Conference
Biopharmaceutical company Immunomedics announced that the company’s president and CEO, Cynthia L. Sullivan, provided an update on Immunomedics’ antibody-drug conjugate (ADC) programs during the company’s presentation at the New York Biotechnology Association’s Annual Meeting on May 29, 2013.
Immunomedics currently has three ADCs in clinical development, but recent results are especially encouraging from the two being studied in patients with advanced solid tumors – particularly metastatic colorectal and triple-negative breast cancers. Tumor shrinkage, including partial responses determined by RECIST criteria, was achieved in dose-escalation trials of IMMU-130 and IMMU-132 ADC product candidates.
Both ADC product candidates involve SN-38, which is the active metabolite of irinotecan – used in treating metastatic colorectal and other cancers – conjugated by Immunomedics’ proprietary technology to labetuzumab (anti-CEACAM5 humanized monoclonal antibody; IMMU-130) or the anti-TROP-2 humanized antibody, hRS7 (IMMU-132). IMMU-130 is being studied in advanced colorectal cancer patients who have failed irinotecan therapy, while IMMU-132 is being tested in 13 types of cancer, including colorectal, triple-negative breast, bladder, pancreas, prostate, kidney, and ovarian.
“Since we have seen tumor shrinkage, including partial responses, so early in these trials, and that SN-38 bound to two different antibodies has been active, our confidence is increased regarding the future potential of these ADC candidates for treating these major cancer types after they become refractive to conventional chemotherapeutic agents,” Sullivan said. “The major toxicities, to date, have been diarrhea and neutropenia, which generally can be alleviated by other medications, and these appear to be less frequent and milder than with irinotecan therapy.”
Sullivan added that the Phase Ib trial of 90Y-clivatuzumab tetraxetan in patients with advanced, third-line pancreatic cancer is nearing completion of follow-up, and analysis of survival results is continuing. The trial compared clivatuzumab alone with the combination of clivatuzumab with low-dose gemcitabine in an open-label, randomized trial.
For more information, visit www.immunomedics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Immunomedics currently has three ADCs in clinical development, but recent results are especially encouraging from the two being studied in patients with advanced solid tumors – particularly metastatic colorectal and triple-negative breast cancers. Tumor shrinkage, including partial responses determined by RECIST criteria, was achieved in dose-escalation trials of IMMU-130 and IMMU-132 ADC product candidates.
Both ADC product candidates involve SN-38, which is the active metabolite of irinotecan – used in treating metastatic colorectal and other cancers – conjugated by Immunomedics’ proprietary technology to labetuzumab (anti-CEACAM5 humanized monoclonal antibody; IMMU-130) or the anti-TROP-2 humanized antibody, hRS7 (IMMU-132). IMMU-130 is being studied in advanced colorectal cancer patients who have failed irinotecan therapy, while IMMU-132 is being tested in 13 types of cancer, including colorectal, triple-negative breast, bladder, pancreas, prostate, kidney, and ovarian.
“Since we have seen tumor shrinkage, including partial responses, so early in these trials, and that SN-38 bound to two different antibodies has been active, our confidence is increased regarding the future potential of these ADC candidates for treating these major cancer types after they become refractive to conventional chemotherapeutic agents,” Sullivan said. “The major toxicities, to date, have been diarrhea and neutropenia, which generally can be alleviated by other medications, and these appear to be less frequent and milder than with irinotecan therapy.”
Sullivan added that the Phase Ib trial of 90Y-clivatuzumab tetraxetan in patients with advanced, third-line pancreatic cancer is nearing completion of follow-up, and analysis of survival results is continuing. The trial compared clivatuzumab alone with the combination of clivatuzumab with low-dose gemcitabine in an open-label, randomized trial.
For more information, visit www.immunomedics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Lpath, Inc. (LPTN) Issued Patent Related to Ocular Drug Program iSONEP
Lpath is a therapeutic antibody company and the category leader in lipid-targeted therapeutics. The company ImmuneY2 drug discovery engine has the unique ability to generate monoclonal antibodies that bind to and inhibit bioactive lipids that contribute to disease. Lpath has three drug candidates currently: Lpathomab, ASONEP, and iSONEP.
The company announced today that it has received official notification from the U.S. Patent and Trademark Office that it has been issued a key patent supporting its iSONEP program. The new patent claims methods of using monoclonal antibodies (including iSONEP) that bind sphingosine-1-phosphate (S1P) in the treatment of a wide variety of ocular conditions, including wet AMD (age-related macular degeneration). The company has a similar patent in Europe.
Lpath is currently conducting a Phase II clinical trial for iSONEP, called Nexus, which is evaluating the anti-S1P antibody’s safety and efficacy in wet-AMD patients. In 2010, the company entered into an agreement with drug giant Pfizer that provides Pfizer an exclusive option for worldwide license to develop and commercialize iSONEP.
The company is also conducting a Phase II trial for ASONEP in renal cell carcinoma patients. Both iSONEP and ASONEP are formulations of sonepcizumab, a first-in-class therapeutic antibody against S1Pdeveloped using Lpath’s ImmuneY2. Antibodies developed using this discovery engine are designed to target bioactive signaling lipids that are involved in cancer, macular degeneration, and many other diseases.
For further information about Lpath, its ImmuneY2 discovery engine, and its drug candidates, please visit www.Lpath.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company announced today that it has received official notification from the U.S. Patent and Trademark Office that it has been issued a key patent supporting its iSONEP program. The new patent claims methods of using monoclonal antibodies (including iSONEP) that bind sphingosine-1-phosphate (S1P) in the treatment of a wide variety of ocular conditions, including wet AMD (age-related macular degeneration). The company has a similar patent in Europe.
Lpath is currently conducting a Phase II clinical trial for iSONEP, called Nexus, which is evaluating the anti-S1P antibody’s safety and efficacy in wet-AMD patients. In 2010, the company entered into an agreement with drug giant Pfizer that provides Pfizer an exclusive option for worldwide license to develop and commercialize iSONEP.
The company is also conducting a Phase II trial for ASONEP in renal cell carcinoma patients. Both iSONEP and ASONEP are formulations of sonepcizumab, a first-in-class therapeutic antibody against S1Pdeveloped using Lpath’s ImmuneY2. Antibodies developed using this discovery engine are designed to target bioactive signaling lipids that are involved in cancer, macular degeneration, and many other diseases.
For further information about Lpath, its ImmuneY2 discovery engine, and its drug candidates, please visit www.Lpath.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Leading Wuhan Supermarket Chain and Tianli Agritech, Inc. (OINK) Partner Up
Leading producer of breeder hogs, market hogs, and black hogs, Tianli Agritech announced that the company has signed a contractual agreement with Zhongbai Warehouse Supermarket Co., Ltd. (“ZHONGBAI”) to sell meat cuts of its Tianli-Xiduhei™ black hog product in five warehouse outlets held by ZHONGBAI’s in Wuhan, Hubei province. Tianli Agritech is currently headquartered in Wuhan City, China.
ZHONGBAI was first established in 1997 and is a wholly owned subsidiary of Zhongbai Holding Group Co. Ltd. (000759.SZ) (“Zhongbai Holding”), a leading supermarket chain in Wuhan. According to its latest Annual Report, Zhongbai Holding is stated to have 244 warehouses, 651 convenience stores, 5 department stores, and 45 electronics stores. Net sales of Zhongbai Holding totaled RMB 15.7 billion in 2012, of which ZHONGBAI produced about RMB 11.2 billion.
Chairwoman and CEO of Tianli Agritech, Hanying Li, commented, “We are very excited to see cuts of our branded black hog meat gain traction in the Wuhan market following our recent entry into the Beijing market. This marks an important milestone for our retail channel buildout effort and could potentially open the door for us to gain broader access to Zhongbai Holding’s network of stores. As we are committed to expand our reach in the Wuhan market and explore other geographic markets, we expect retail sales of our black hog products to generate meaningful revenue and earnings in coming quarters.”
Tianli’s black hogs and Tianli-Xiduhei™ meat cuts are items that are a part of the company’s “10,000 families and 1,000,000 Black Hogs” program in the Enshi Prefecture, Hubei Province. The company provided funds totaling $12.67 million and completed the construction of 765 black hog farms in Enshi Prefecture by March’s 2013 end.
To learn more, please visit www.weitian-ir.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
ZHONGBAI was first established in 1997 and is a wholly owned subsidiary of Zhongbai Holding Group Co. Ltd. (000759.SZ) (“Zhongbai Holding”), a leading supermarket chain in Wuhan. According to its latest Annual Report, Zhongbai Holding is stated to have 244 warehouses, 651 convenience stores, 5 department stores, and 45 electronics stores. Net sales of Zhongbai Holding totaled RMB 15.7 billion in 2012, of which ZHONGBAI produced about RMB 11.2 billion.
Chairwoman and CEO of Tianli Agritech, Hanying Li, commented, “We are very excited to see cuts of our branded black hog meat gain traction in the Wuhan market following our recent entry into the Beijing market. This marks an important milestone for our retail channel buildout effort and could potentially open the door for us to gain broader access to Zhongbai Holding’s network of stores. As we are committed to expand our reach in the Wuhan market and explore other geographic markets, we expect retail sales of our black hog products to generate meaningful revenue and earnings in coming quarters.”
Tianli’s black hogs and Tianli-Xiduhei™ meat cuts are items that are a part of the company’s “10,000 families and 1,000,000 Black Hogs” program in the Enshi Prefecture, Hubei Province. The company provided funds totaling $12.67 million and completed the construction of 765 black hog farms in Enshi Prefecture by March’s 2013 end.
To learn more, please visit www.weitian-ir.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, May 29, 2013
Centor, Inc. (CNTO) Expands Gold Footprint in Ghana, Exercises Achaa Concession Purchase Option
Centor is intelligently taking advantage of their own strong position, as well as external, consolidative forces in the resource sector to help build their already strong project portfolio (15.5 sq mile Nobewam project in the Kumasi basin, near the 4M oz Konongo mine) in Ghana’s rich, under-developed mineral base, and the company was pleased to report today that they have exercised their option to purchase the Achaa Mining Company concession at Anyinaso, just 18.5 miles south of Newmont’s Kenyasi mine.
The 10.3 square mile Anyinaso Concession lies in the heart of the prolific (and by now world-famous) Ashanti Gold Belt, which shows ankerite, calcite, magnesite, and siderite in all host and mineralized rocks (spec. Bogoso/Prestea mining districts). This is one of the key gold areas in the world right now and CNTO is cozied up alongside majors in the race to grab prime acreage, as a much smaller player with tremendous potential upside on their deposits for investors.
Initial recon and analytical exploration efforts on Anyinaso have yielded promising returns and CNTO management is confident that results will pan out handsomely during the 6-month window allowed under the option agreement for testing. In fact, CNTO is hard at work on the test program’s details right now, hammering out the profile of a rigorous soil sampling effort for one of the choice target areas, a nice big slice between the Offin Shelterbelt Forest Reserve and the Awontaso River.
More western Kumasi basin potential here for CNTO, just at the northern arm of the Safi Belt in territory that has been extensively looked at by Newmont and others, validating the mineralization potential in spades. We have some huge vectors here for not just structural contact, but all kinds of intrabasinal sediment and the property is up from the 300k oz (over seven years) alluvial, Jeni River Concession, meaning much of that gold potentially came out of the hard rock at Anyinaso. Not so far north as Newmont’s Kenyasi mine, about 4.3 miles north of Anyinaso, we have the site where Ashanti-Bibini open-pitted some 100k ounces of Au via the exceptional Mpesetia deposit.
Just to the southeast another four open pit operations, collectively, within the last decade have pulled out a whopping 30M tons at 2g/t and it seems certain that, given the structural similarities between the proximal open pit operations, the regional geology, and the initial Anyinaso findings, high confidence at CNTO is well-deserved about Anyinaso’s long-term profitability for shareholders. If production is in line with estimates based on these metrics, data coming out of the next phase of testing, for which CNTO is now poised, should impress both investor and shareholder alike.
You can take a look at the Terminal Report on Nobewam (PDF) and the Geological Report on Anyinaso (PDF), or get more general info on Centor, Inc., at www.CentorResources.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The 10.3 square mile Anyinaso Concession lies in the heart of the prolific (and by now world-famous) Ashanti Gold Belt, which shows ankerite, calcite, magnesite, and siderite in all host and mineralized rocks (spec. Bogoso/Prestea mining districts). This is one of the key gold areas in the world right now and CNTO is cozied up alongside majors in the race to grab prime acreage, as a much smaller player with tremendous potential upside on their deposits for investors.
Initial recon and analytical exploration efforts on Anyinaso have yielded promising returns and CNTO management is confident that results will pan out handsomely during the 6-month window allowed under the option agreement for testing. In fact, CNTO is hard at work on the test program’s details right now, hammering out the profile of a rigorous soil sampling effort for one of the choice target areas, a nice big slice between the Offin Shelterbelt Forest Reserve and the Awontaso River.
More western Kumasi basin potential here for CNTO, just at the northern arm of the Safi Belt in territory that has been extensively looked at by Newmont and others, validating the mineralization potential in spades. We have some huge vectors here for not just structural contact, but all kinds of intrabasinal sediment and the property is up from the 300k oz (over seven years) alluvial, Jeni River Concession, meaning much of that gold potentially came out of the hard rock at Anyinaso. Not so far north as Newmont’s Kenyasi mine, about 4.3 miles north of Anyinaso, we have the site where Ashanti-Bibini open-pitted some 100k ounces of Au via the exceptional Mpesetia deposit.
Just to the southeast another four open pit operations, collectively, within the last decade have pulled out a whopping 30M tons at 2g/t and it seems certain that, given the structural similarities between the proximal open pit operations, the regional geology, and the initial Anyinaso findings, high confidence at CNTO is well-deserved about Anyinaso’s long-term profitability for shareholders. If production is in line with estimates based on these metrics, data coming out of the next phase of testing, for which CNTO is now poised, should impress both investor and shareholder alike.
You can take a look at the Terminal Report on Nobewam (PDF) and the Geological Report on Anyinaso (PDF), or get more general info on Centor, Inc., at www.CentorResources.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Digital Cinema Destinations Corp. (DCIN) Capitalizes on the Evolution of Film
Digital Cinema CEO Bud Mayo started his career in the film industry 26 years ago, shortly after the PG-13 rating was introduced and the trend for “blockbuster” films began to really pick up pace.
In 1987 Mayo acquired his first theater in New Jersey and continued to strengthen his portfolio, amassing 45 theaters by 1998. He then decided to take these assets public under Clearview Cinema Group, Inc., which he sold to Cablevision Systems Corp. for $160 million.
As Deal Pipeline writer Richard Morgan puts it, Mayo then worked for Cablevision as president and CEO of its cinema division for a year before exiting and “reinvent[ing] himself as the leader in converting the industry from 35-millimeter film to digital projection.”
The film industry was in the midst of significant evolution from film to digital and Mayo recognized this trend designed Virtual Print Fee (VPF) as a means for studios to fund significant upgrades needed to replace their film projectors with digital equipment and technology. By definition, VPFs are a subsidy paid by a film distributor allocated to the purchase of digital cinema projection equipment – this fee is paid in the form of a fee per booking of a movie to counter the savings from the film exhibitor not having to ship a film print.
Fast-forward to date, and nearly all U.S. and Canadian theaters are fully converted to digital, which means the VPFs in their success have nearly worked themselves out of a job. Not one to let history or opportunity pass him by, Mayo has identified another means of revenue generation: alternative programming.
Mayo believes alternative programming has the potential to boost theater revenue by 20 percent. The instrument to execute alternative programming is his current endeavor, Digital Cinema.
Founded in 2010, Digital Cinema executed its Initial Public Offering in 2012 and now has 18 theaters with 178 screens. The company’s goal is to establish a national presence with 100 theaters and 1,000 screens by year-end.
“Mayo said his deal pipeline remains sufficiently robust to sustain rapid growth and consists primarily of theater-owning families with estate-planning objectives or liquidity needs (most likely caused, in some cases, by debt assumed to facilitate digital conversion). By adding scale, Digital Cinema’s so-called Digiplex Destinations can increase efficiencies in matters as mundane as the purchase of popcorn and other cinema staples. And by limiting his deals to those with accretive possibilities, he hopes to induce capital providers to continue funding his company’s acquisition spree,” writes Morgan.
This alternative programming includes unique film features such as the May 4 boxing match between Floyd Mayweather and Robert Guerrero, which Digital Cinema beamed live from Las Vegas to 10 of his 18 theaters. The showings aren’t limited to professional fights, but do cater to “cultish offerings” such as extreme sports.
Mayo says the showing of the events is quickly gaining traction and is already tightly woven into Digital Cinema’s business plan … so much so that Mayo would like to reclaim ownership of Clearview Cinemas, which Cablevision sold to Bow Tie Cinemas LLC, reports Morgan.
To read Richard Morgan’s full article, visit: http://dtg.fm/PR2s
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
In 1987 Mayo acquired his first theater in New Jersey and continued to strengthen his portfolio, amassing 45 theaters by 1998. He then decided to take these assets public under Clearview Cinema Group, Inc., which he sold to Cablevision Systems Corp. for $160 million.
As Deal Pipeline writer Richard Morgan puts it, Mayo then worked for Cablevision as president and CEO of its cinema division for a year before exiting and “reinvent[ing] himself as the leader in converting the industry from 35-millimeter film to digital projection.”
The film industry was in the midst of significant evolution from film to digital and Mayo recognized this trend designed Virtual Print Fee (VPF) as a means for studios to fund significant upgrades needed to replace their film projectors with digital equipment and technology. By definition, VPFs are a subsidy paid by a film distributor allocated to the purchase of digital cinema projection equipment – this fee is paid in the form of a fee per booking of a movie to counter the savings from the film exhibitor not having to ship a film print.
Fast-forward to date, and nearly all U.S. and Canadian theaters are fully converted to digital, which means the VPFs in their success have nearly worked themselves out of a job. Not one to let history or opportunity pass him by, Mayo has identified another means of revenue generation: alternative programming.
Mayo believes alternative programming has the potential to boost theater revenue by 20 percent. The instrument to execute alternative programming is his current endeavor, Digital Cinema.
Founded in 2010, Digital Cinema executed its Initial Public Offering in 2012 and now has 18 theaters with 178 screens. The company’s goal is to establish a national presence with 100 theaters and 1,000 screens by year-end.
“Mayo said his deal pipeline remains sufficiently robust to sustain rapid growth and consists primarily of theater-owning families with estate-planning objectives or liquidity needs (most likely caused, in some cases, by debt assumed to facilitate digital conversion). By adding scale, Digital Cinema’s so-called Digiplex Destinations can increase efficiencies in matters as mundane as the purchase of popcorn and other cinema staples. And by limiting his deals to those with accretive possibilities, he hopes to induce capital providers to continue funding his company’s acquisition spree,” writes Morgan.
This alternative programming includes unique film features such as the May 4 boxing match between Floyd Mayweather and Robert Guerrero, which Digital Cinema beamed live from Las Vegas to 10 of his 18 theaters. The showings aren’t limited to professional fights, but do cater to “cultish offerings” such as extreme sports.
Mayo says the showing of the events is quickly gaining traction and is already tightly woven into Digital Cinema’s business plan … so much so that Mayo would like to reclaim ownership of Clearview Cinemas, which Cablevision sold to Bow Tie Cinemas LLC, reports Morgan.
To read Richard Morgan’s full article, visit: http://dtg.fm/PR2s
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
FormFactor, Inc. (FORM) Recognized as Leading Worldwide Supplier of Advanced Semiconductor Probe Cards
FormFactor, the premier supplier of advanced probe cards to the memory market, was recognized at the top advanced semiconductor probe card supplier for both memory and non-memory markets by leading research firm, VLSIresearch. This announcement comes on the heels of FormFactor’s merger with MicroProbe, the principal advanced probe card vendor in the SoC market, last year.
Combined, FormFactor and Microprobe boast $262 million in revenue, making them the largest probe card player in the semiconductor industry. In just the advanced probe card sector, combined revenue reached $252 million, a total that was over 50 percent higher than the nearest competitor. This performance gap is even more pronounced for MEMS probe cards where combined revenue was double the nearest competitor at over $216 million.
According to the VLSIresearch survey, “The Probe Card Market – 2012 Survey Results & Forecast Update,” worldwide sales of semiconductor probe cards for 2012 was $1.2 billion. Advanced probe cards accounted for 76 percent of the total market. Within this sector, advanced non-memory probe card sales grew by 14 percent — outpacing all other sectors. The VLSIresearch survey projects the semiconductor probe card industry as a whole will see sustained growth through 2017 when sales are expected to top $1.7 billion.
“FormFactor’s strong showing in this year’s survey is attributed to the company’s progress in DRAM device test, as well as a steady migration by customers to new SoC packaging applications like flip-chip and copper pillars,” said CEO Tom St. Dennis. “Complex applications — essential enablers of consumer mobile products — depend on advanced probe cards that can meet rigorous test requirements while simultaneously lowering overall test costs. We’re pleased to lead this sector by providing exceptional technology solutions to our customers, and we’re proud to rank highly in this respected survey.”
VLSIresearch President Risto Puhakka said, “2012 was a good year for FormFactor. Together with MicroProbe they’ve got the technology and products to address IC requirements across the entire advanced probe card space. Furthermore, they’re moving fast with combined R&D initiatives to master challenging applications with robust solutions. The merger created a formidable new probe card company with strong competitive advantages.”
For further information, visit www.formfactor.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Combined, FormFactor and Microprobe boast $262 million in revenue, making them the largest probe card player in the semiconductor industry. In just the advanced probe card sector, combined revenue reached $252 million, a total that was over 50 percent higher than the nearest competitor. This performance gap is even more pronounced for MEMS probe cards where combined revenue was double the nearest competitor at over $216 million.
According to the VLSIresearch survey, “The Probe Card Market – 2012 Survey Results & Forecast Update,” worldwide sales of semiconductor probe cards for 2012 was $1.2 billion. Advanced probe cards accounted for 76 percent of the total market. Within this sector, advanced non-memory probe card sales grew by 14 percent — outpacing all other sectors. The VLSIresearch survey projects the semiconductor probe card industry as a whole will see sustained growth through 2017 when sales are expected to top $1.7 billion.
“FormFactor’s strong showing in this year’s survey is attributed to the company’s progress in DRAM device test, as well as a steady migration by customers to new SoC packaging applications like flip-chip and copper pillars,” said CEO Tom St. Dennis. “Complex applications — essential enablers of consumer mobile products — depend on advanced probe cards that can meet rigorous test requirements while simultaneously lowering overall test costs. We’re pleased to lead this sector by providing exceptional technology solutions to our customers, and we’re proud to rank highly in this respected survey.”
VLSIresearch President Risto Puhakka said, “2012 was a good year for FormFactor. Together with MicroProbe they’ve got the technology and products to address IC requirements across the entire advanced probe card space. Furthermore, they’re moving fast with combined R&D initiatives to master challenging applications with robust solutions. The merger created a formidable new probe card company with strong competitive advantages.”
For further information, visit www.formfactor.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Jameson Stanford Resources Corp. (JMSN) Completes Reverse Merger
Jameson Stanford Resources, a metals and minerals exploration, development, and production company, announced this morning that it has completed its reverse merger. The Company is now a fully reporting public company with its shares quoted on the Over The Counter Bulletin Board under the symbol JMSN.
“This is a very proud day and the completion of this reverse merger represents a critical step in the execution of our company’s business model,” stated Michael Stanford, President and CEO of Jameson Stanford Resources. “We are building what we believe will soon be recognized as the premier supplier of metal ore, mineral products and metallurgical services to regional customers.”
Jameson Stanford Resources is currently developing three different areas in the foothills outside of Salt Lake City. These three projects represent a very credible opportunity for the extraction and sale of high quality ores and precious metals. The company promised further details via a separate press release in the very near future.
For more information, visit www.jamesonstanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
“This is a very proud day and the completion of this reverse merger represents a critical step in the execution of our company’s business model,” stated Michael Stanford, President and CEO of Jameson Stanford Resources. “We are building what we believe will soon be recognized as the premier supplier of metal ore, mineral products and metallurgical services to regional customers.”
Jameson Stanford Resources is currently developing three different areas in the foothills outside of Salt Lake City. These three projects represent a very credible opportunity for the extraction and sale of high quality ores and precious metals. The company promised further details via a separate press release in the very near future.
For more information, visit www.jamesonstanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cerus Corp. (CERS) Forges Five-Year INTERCEPT Platelet Agreement with First Danish Hospital
Biomedical products company Cerus has announced that Aalborg University Hospital, Denmark, has signed a five-year project collaboration agreement for the company’s INTERCEPT Blood System for platelets.
Aalborg University Hospital is the first hospital in Denmark to adopt INTERCEPT. The hospital’s department of FBE Klinisk Immunologi transfuses approximately 2,200 platelet units each year to Region Nordjylland, which represents around 6% of Denmark’s platelet market.
One of the most rampant infectious risks in blood transfusion is bacterial contamination of platelets, which poses serious health risks to transfusion patients. Cerus believes the INTERCEPT Blood system will substantially reduce residual risk due to bacterial contamination, also offering significant operational advantages like reduced waste rates.
INTERCEPT has shown improved patient outcomes over 10 years of routine use, as supported by hemovigilance data in which INTERCEPT-treated platelet components prevented septic transfusion reactions. Also favorably impacted have been logistics and component availability, resulting in cost-effective blood center operations.
Aalborg University Hospital has a proactive approach to protecting patients against transfusion-transmitted infections, and Cerus looks forward to working with the hospital in these efforts to improve blood safety. In the future, Cerus hopes to extend implementation of INTERCEPT platelets to other Danish centers.
For more information, visit www.cerus.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Aalborg University Hospital is the first hospital in Denmark to adopt INTERCEPT. The hospital’s department of FBE Klinisk Immunologi transfuses approximately 2,200 platelet units each year to Region Nordjylland, which represents around 6% of Denmark’s platelet market.
One of the most rampant infectious risks in blood transfusion is bacterial contamination of platelets, which poses serious health risks to transfusion patients. Cerus believes the INTERCEPT Blood system will substantially reduce residual risk due to bacterial contamination, also offering significant operational advantages like reduced waste rates.
INTERCEPT has shown improved patient outcomes over 10 years of routine use, as supported by hemovigilance data in which INTERCEPT-treated platelet components prevented septic transfusion reactions. Also favorably impacted have been logistics and component availability, resulting in cost-effective blood center operations.
Aalborg University Hospital has a proactive approach to protecting patients against transfusion-transmitted infections, and Cerus looks forward to working with the hospital in these efforts to improve blood safety. In the future, Cerus hopes to extend implementation of INTERCEPT platelets to other Danish centers.
For more information, visit www.cerus.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Real Goods, Inc. (RSOL) Solar Selected to Aid in Expansion of Solar Adoption in Select Massachusetts Communities
Real Goods Solar, a nationwide leader of turnkey solar energy solutions for residential, commercial, and utility customers, yesterday announced that it has been selected as a 2013 Solarize Mass Installer by the Massachusetts Clean Energy Center (MassCEC) and the Green Communities Division of the MA Department of Energy Resources (DOER) to bring solar electricity to home and business owners in Massachusetts through the Solarize Mass program.
Real Goods Solar, in partnership with MassCEC, will work with Solarize Mass Community Solar Coaches to implement the Solarize Mass program in the Massachusetts communities of Northampton, Lee, and Williamstown.
The goal of the Solarize programs is to increase the adoption of solar energy and further reduce the overall cost of solar power. Additionally, the program offers residents and businesses discounted pricing for solar through tiered community-based incentives. Greater savings can be enjoyed as more members of a particular community participate.
“We’ve realized great success with previous Solarize programs, and we expect this one to be even stronger,” commented Real Goods Solar CEO Kam Mofid. “Through the 2011 Solarize Mass Pilot program, Real Goods Solar helped Hatfield and Winchester Massachusetts collectively achieve more than 200 kilowatts of solar power capacity. We were also able to more than double the amount of solar in Portland, Connecticut by installing more than 342 kilowatts through the Solarize Connecticut pilot program.”
Beginning April 2013, as part of the effort to reach Governor Patrick’s goal of 250 megawatts of solar power installed by 2017, Massachusetts Energy and Environmental Affairs Secretary Richard K. Sullivan Jr. announced that MassCEC and the Department of Energy Resources had selected the cities and towns of Bourne, Brookline, Carlisle, Chelmsford, Lee, Medford, Medway, Newton, Northampton, and Williamstown to participate in the first round of the 2013 Solarize Mass program. The state is close to reaching its goal – 243 megawatts of solar electricity installed to date or the equivalent of powering 38,000 homes for a year as a result of the Solarize mass program and other incentives.
MassCEC CEO Alicia Barton, said, “This program brings together residents, local and state officials, and solar industry workers to form a truly grassroots effort. With everyone at the table, we can spread the word about the economic and environmental benefits of solar power across 10 communities.”
The Solarize Mass programs in Lee, Williamstown and Northampton are planned to continue through summer. Home and business owners will have until September 30, 2013 to register for their savings.
For more information on Real Goods Solar, please visit www.RealGoodsSolar.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Real Goods Solar, in partnership with MassCEC, will work with Solarize Mass Community Solar Coaches to implement the Solarize Mass program in the Massachusetts communities of Northampton, Lee, and Williamstown.
The goal of the Solarize programs is to increase the adoption of solar energy and further reduce the overall cost of solar power. Additionally, the program offers residents and businesses discounted pricing for solar through tiered community-based incentives. Greater savings can be enjoyed as more members of a particular community participate.
“We’ve realized great success with previous Solarize programs, and we expect this one to be even stronger,” commented Real Goods Solar CEO Kam Mofid. “Through the 2011 Solarize Mass Pilot program, Real Goods Solar helped Hatfield and Winchester Massachusetts collectively achieve more than 200 kilowatts of solar power capacity. We were also able to more than double the amount of solar in Portland, Connecticut by installing more than 342 kilowatts through the Solarize Connecticut pilot program.”
Beginning April 2013, as part of the effort to reach Governor Patrick’s goal of 250 megawatts of solar power installed by 2017, Massachusetts Energy and Environmental Affairs Secretary Richard K. Sullivan Jr. announced that MassCEC and the Department of Energy Resources had selected the cities and towns of Bourne, Brookline, Carlisle, Chelmsford, Lee, Medford, Medway, Newton, Northampton, and Williamstown to participate in the first round of the 2013 Solarize Mass program. The state is close to reaching its goal – 243 megawatts of solar electricity installed to date or the equivalent of powering 38,000 homes for a year as a result of the Solarize mass program and other incentives.
MassCEC CEO Alicia Barton, said, “This program brings together residents, local and state officials, and solar industry workers to form a truly grassroots effort. With everyone at the table, we can spread the word about the economic and environmental benefits of solar power across 10 communities.”
The Solarize Mass programs in Lee, Williamstown and Northampton are planned to continue through summer. Home and business owners will have until September 30, 2013 to register for their savings.
For more information on Real Goods Solar, please visit www.RealGoodsSolar.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
BG Medicine, Inc. (BGMD) Video Chart for Wednesday, May 29, 2013
BGMD had a strong day on Tuesday, rising more than 13 percent. The chart is slowly making higher lows, which could be signaling the start of the right-hand side of a large, rounded bottom. The stock has a history of starting some days strong and closing relatively weak, so technical traders will be looking to see if Tuesday’s move was a prelude of bigger things to come or just a head fake.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Chanticleer Holdings, Inc. (HOTR) is Ahead of the Game in Africa
In an online QSR Magazine article by Laurel Nakkas (Africa: The Final Frontier – http://dtg.fm/FQ1x), a good case is made for Africa as the business world’s next and most logical growth target, especially for popular U.S. restaurant chains looking to expand beyond already saturated global markets.
Africa, the second biggest continent in the world in both size and population, represents a highly diverse market of over a billion people. Population diversity and underdeveloped infrastructure, together with political volatility, has, until recently, diverted much American consumer-oriented business investment to other parts of the world. But that’s now starting to change with rising economies, demand for African resources, and a more optimistic sense about the long-term prospects for the political climate. While Africa has begun rising on the business radar, attraction to other parts of the world has begun to fade as competition has put pressure on expected returns. The article refers to a projection by global management consulting firm McKinsey & Company that African consumer-facing industries will grow to more than $400 billion by 2020.
As a real-life example, the article points to Cinnabon and its experience as the first U.S. food franchise to enter Libya. Cinnabon had to address unique training and logistical issues as well as political instability. But what they discovered was that market demand was strong and sufficient to overcome all of these challenges, making the brand a success and leading to current plans for several additional locations. Moreover, the company is now eyeing a number of other untapped countries in Africa, establishing a foothold well ahead of the crowd. Cinnabon, of course, is not alone. KFC, the biggest U.S. quick-serve chain on the continent, is now in over a dozen countries in Africa, with many more planned.
One of the most promising countries in Africa is South Africa, with over 50 million people along with well-developed financial, legal, communications, energy, and transport sectors. Although South Africa, like other countries in Africa, is going through the painful process of restructuring and modernizing its economy, it remains the biggest economy in Africa, with prime opportunities for well-planned U.S. food franchises.
Chanticleer Holdings, a joint owner of privately held Hooters of America (HOA) and an independent developer of international Hooters restaurants, was an early recognizer of the possibilities in South Africa and already has majority interest in multiple Hooters restaurants in the country. Chanticleer now anticipates as many as 20 Hooters restaurants in South Africa, in addition to restaurants it has opened or is planning to open in Europe, Australia, and Brazil.
For additional information on Chanticleer Holdings, visit www.ChanticleerHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Africa, the second biggest continent in the world in both size and population, represents a highly diverse market of over a billion people. Population diversity and underdeveloped infrastructure, together with political volatility, has, until recently, diverted much American consumer-oriented business investment to other parts of the world. But that’s now starting to change with rising economies, demand for African resources, and a more optimistic sense about the long-term prospects for the political climate. While Africa has begun rising on the business radar, attraction to other parts of the world has begun to fade as competition has put pressure on expected returns. The article refers to a projection by global management consulting firm McKinsey & Company that African consumer-facing industries will grow to more than $400 billion by 2020.
As a real-life example, the article points to Cinnabon and its experience as the first U.S. food franchise to enter Libya. Cinnabon had to address unique training and logistical issues as well as political instability. But what they discovered was that market demand was strong and sufficient to overcome all of these challenges, making the brand a success and leading to current plans for several additional locations. Moreover, the company is now eyeing a number of other untapped countries in Africa, establishing a foothold well ahead of the crowd. Cinnabon, of course, is not alone. KFC, the biggest U.S. quick-serve chain on the continent, is now in over a dozen countries in Africa, with many more planned.
One of the most promising countries in Africa is South Africa, with over 50 million people along with well-developed financial, legal, communications, energy, and transport sectors. Although South Africa, like other countries in Africa, is going through the painful process of restructuring and modernizing its economy, it remains the biggest economy in Africa, with prime opportunities for well-planned U.S. food franchises.
Chanticleer Holdings, a joint owner of privately held Hooters of America (HOA) and an independent developer of international Hooters restaurants, was an early recognizer of the possibilities in South Africa and already has majority interest in multiple Hooters restaurants in the country. Chanticleer now anticipates as many as 20 Hooters restaurants in South Africa, in addition to restaurants it has opened or is planning to open in Europe, Australia, and Brazil.
For additional information on Chanticleer Holdings, visit www.ChanticleerHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Accuray, Inc. (ARAY) Receives Omega Management Group Award for Excellent Customer Service and Support
Today, Accuray announced it has received Omega Management Group Corp.’s NorthFace ScoreBoard Award in recognition for its customer service and support in 2012. Since 2000, the award has been given to companies who exceed expectations in customer satisfaction, based on the company’s customer ratings over the past year. Accuray will be recognized along with other NorthFace ScoreBoard Award recipients at a special awards dinner taking place at Omega’s annual SCORE Conference from May 29-31, 2013.
“Accuray is very pleased to have earned the NorthFace ScoreBoard Award for outstanding customer service the second year in a row,” said Bob Ragusa, Accuray’s executive vice president, engineering and global operations. “At Accuray, we are focused on ensuring our customers receive consistent high quality service and support so they can focus on their key mission of effectively and efficiently treating cancer patients. This award is recognition of the hard work of our entire global Service and Support team throughout the past year.”
Omega measures customer satisfaction and loyalty levels on a 5-point scale (or equivalent) at least four times during the year in such categories as technical support, field service, customer service, and account management. NorthFace ScoreBoard Award recipients are companies who, based solely on survey responses from their own customers, achieved a 4.0 or above out of a possible 5.0.
“The NorthFace ScoreBoard Award recognizes organizations who not only offer exemplary customer service, but who also center their existence on a deep commitment to exceeding customer expectations,” said Omega’s CEO, John Alexander Maraganis. “In 2012, more than 200 projects, many international in scope, were audited from 55 companies based in the U.S. and abroad. The majority of companies are repeat recipients, which shows that, despite the tough economy, implementing a CEM strategy is a reliable, proven way to achieve business success.”
Maraganis continued, “Because of its unique ‘customer-only vote’ criteria, the NorthFace ScoreBoard Award has been viewed from its inception as the only objective benchmark for excellence in customer service. Our research indicates that companies that consistently achieve a 4.0 rating or above, which we call the ‘Loyalty Zone,’ are succeeding in locking in profitable, long-term customer relationships, and this significantly raises the bar on their competitors.”
For more information, please visit www.accuray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Accuray is very pleased to have earned the NorthFace ScoreBoard Award for outstanding customer service the second year in a row,” said Bob Ragusa, Accuray’s executive vice president, engineering and global operations. “At Accuray, we are focused on ensuring our customers receive consistent high quality service and support so they can focus on their key mission of effectively and efficiently treating cancer patients. This award is recognition of the hard work of our entire global Service and Support team throughout the past year.”
Omega measures customer satisfaction and loyalty levels on a 5-point scale (or equivalent) at least four times during the year in such categories as technical support, field service, customer service, and account management. NorthFace ScoreBoard Award recipients are companies who, based solely on survey responses from their own customers, achieved a 4.0 or above out of a possible 5.0.
“The NorthFace ScoreBoard Award recognizes organizations who not only offer exemplary customer service, but who also center their existence on a deep commitment to exceeding customer expectations,” said Omega’s CEO, John Alexander Maraganis. “In 2012, more than 200 projects, many international in scope, were audited from 55 companies based in the U.S. and abroad. The majority of companies are repeat recipients, which shows that, despite the tough economy, implementing a CEM strategy is a reliable, proven way to achieve business success.”
Maraganis continued, “Because of its unique ‘customer-only vote’ criteria, the NorthFace ScoreBoard Award has been viewed from its inception as the only objective benchmark for excellence in customer service. Our research indicates that companies that consistently achieve a 4.0 rating or above, which we call the ‘Loyalty Zone,’ are succeeding in locking in profitable, long-term customer relationships, and this significantly raises the bar on their competitors.”
For more information, please visit www.accuray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
BIOLASE Inc. (BIOL) Given New Patent for Treating Broad Range of Eye Conditions
BIOLASE develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners. The company’s principal products are revolutionary dental laser systems, making it the world’s leading manufacturer and distributor of dental lasers.
The company announced today that the U.S. Patent and Trademark Office issued it a new patent covering the use of its laser technologies for treating various conditions of the eye, including cataracts, glaucoma, and presbyopia. The patent significantly broadens the claims for the patent family and anticipates using complimentary technologies to streamline procedures to identify the rigidity of the eye to optimize treatment locations in presbyopia procedures, for example.
The latest patent grant is the tenth U.S. patent issued under the “Methods for Treating Eye Conditions” patent family. Three other patents have been issued internationally and six more are pending worldwide. BIOLASE now holds a total of 20 issued and 20 pending U.S. and international patents in seven patent families in the field of ophthalmology. The patents give the company and its OCCULASE subsidiary a wide range of potential applications and coverage in the field.
This new patent is important for the company and its innovative WaterLase technology. Marcia Van Valen, director of business development for BIOLASE, said the patent further leverages the firm’s technology and broadens the patent family “to allow the laser parameters and groupings of tissue treatment to compensate for correlation in the various layers in ocular tissue for treating eye conditions such as presbyopia, cataract and glaucoma.”
For additional information about BIOLASE and its laser technologies, please visit www.biolase.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company announced today that the U.S. Patent and Trademark Office issued it a new patent covering the use of its laser technologies for treating various conditions of the eye, including cataracts, glaucoma, and presbyopia. The patent significantly broadens the claims for the patent family and anticipates using complimentary technologies to streamline procedures to identify the rigidity of the eye to optimize treatment locations in presbyopia procedures, for example.
The latest patent grant is the tenth U.S. patent issued under the “Methods for Treating Eye Conditions” patent family. Three other patents have been issued internationally and six more are pending worldwide. BIOLASE now holds a total of 20 issued and 20 pending U.S. and international patents in seven patent families in the field of ophthalmology. The patents give the company and its OCCULASE subsidiary a wide range of potential applications and coverage in the field.
This new patent is important for the company and its innovative WaterLase technology. Marcia Van Valen, director of business development for BIOLASE, said the patent further leverages the firm’s technology and broadens the patent family “to allow the laser parameters and groupings of tissue treatment to compensate for correlation in the various layers in ocular tissue for treating eye conditions such as presbyopia, cataract and glaucoma.”
For additional information about BIOLASE and its laser technologies, please visit www.biolase.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, May 28, 2013
Ocean Bio-Chem, Inc. (OBCI) Highlights Potential of Company, Including New Liquid Disinfectant
Ocean Bio-Chem is primarily engaged in the manufacturing, marketing, and distribution of a broad line of appearance, performance, and maintenance products for boats, recreational vehicles, automobiles, power sports, outdoor power equipment, and motorcycle markets. The company sells its products in the United States and Canada under the Star brite, StarTron, and other trademarks.
The company’s chairman and CEO, Peter Dornau, was recently interviewed by CEOLive.TV. During the interview, he talked about Ocean Bio-Chem’s achievements, the unique quality of its products, business strategy, and growth opportunities for the firm. The interview can be found on YouTube.
In the course of the interview, Dornau focused on the large growth opportunities the company has with its recently EPA-approved new product, ‘Xtrem-A-Cide P’. This product utilizes Ocean Bio-Chem’s patented technology to generate a chlorine dioxide solution which can applied as a deep-penetrating spray for easy application for surface elimination of MRSA, salmonella, H1V1, Hepatitus A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37, E-coli and other germs, viruses, and fungi.
Dornay explained there is a tremendous market for this new product. Possible users include housewives, schools, hospitals, cruise ships, hotels and other hospitality facilities, gyms and health clubs, sports arenas and stadiums, food processing operations, and rest rooms at businesses. For additional information about Ocean Bio-Chem, visit www.oceanbiochem.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company’s chairman and CEO, Peter Dornau, was recently interviewed by CEOLive.TV. During the interview, he talked about Ocean Bio-Chem’s achievements, the unique quality of its products, business strategy, and growth opportunities for the firm. The interview can be found on YouTube.
In the course of the interview, Dornau focused on the large growth opportunities the company has with its recently EPA-approved new product, ‘Xtrem-A-Cide P’. This product utilizes Ocean Bio-Chem’s patented technology to generate a chlorine dioxide solution which can applied as a deep-penetrating spray for easy application for surface elimination of MRSA, salmonella, H1V1, Hepatitus A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37, E-coli and other germs, viruses, and fungi.
Dornay explained there is a tremendous market for this new product. Possible users include housewives, schools, hospitals, cruise ships, hotels and other hospitality facilities, gyms and health clubs, sports arenas and stadiums, food processing operations, and rest rooms at businesses. For additional information about Ocean Bio-Chem, visit www.oceanbiochem.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
ZAGG, Inc. (ZAGG) Named Google Trusted Store
Leading mobile device accessories company ZAGG, whose portfolio includes ZAGG and iFrogz products, has officially been accepted into the Google Trusted Stores Program. The program, which is offered by Google, helps consumers identify trustworthy online retailers.
In order to participate in the Google Trusted Stores Program, online merchants must meet strict criteria for shipping and customer service regulations. Google followed ZAGG’s performance metrics for one month and with qualifications met awarded the website its badge of acceptance. Factors that influence Google’s selection of a retailer into its program include on-time shipping, any issues being resolved quickly, and a low number of customers needing additional assistance.
In addition Google offers it’s coveted purchase protection for merchandise from Google Trusted Stores, should specific problems arise. Further information about the program can be found at www.google.com/trustedstores.
“Earning the Google Trusted Stores badge is a significant achievement for ZAGG, and it demonstrates our commitment to world-class customer service,” stated Derek Smith, Executive Vice President of Sales for ZAGG. “Our goal is to provide the best possible user experience to our customers and to quickly resolve any issues if they arise.”
ZAGG currently designs, produces, and distributes creative product solutions for mobile and media accessories. For additional information about ZAGG, visit www.ZAGG.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
In order to participate in the Google Trusted Stores Program, online merchants must meet strict criteria for shipping and customer service regulations. Google followed ZAGG’s performance metrics for one month and with qualifications met awarded the website its badge of acceptance. Factors that influence Google’s selection of a retailer into its program include on-time shipping, any issues being resolved quickly, and a low number of customers needing additional assistance.
In addition Google offers it’s coveted purchase protection for merchandise from Google Trusted Stores, should specific problems arise. Further information about the program can be found at www.google.com/trustedstores.
“Earning the Google Trusted Stores badge is a significant achievement for ZAGG, and it demonstrates our commitment to world-class customer service,” stated Derek Smith, Executive Vice President of Sales for ZAGG. “Our goal is to provide the best possible user experience to our customers and to quickly resolve any issues if they arise.”
ZAGG currently designs, produces, and distributes creative product solutions for mobile and media accessories. For additional information about ZAGG, visit www.ZAGG.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Virtual Piggy, Inc. (VPIG) Teams Up with JumpStart to Expand, Enhance Gaming Portfolio
Virtual Piggy, the first e-commerce solution that enables kids to manage and spend money within parental controls, has partnered with JumpStart, an award-winning educational software developer.
The partnership will leverage JumpStart’s technology that allows for simultaneous, real-time gameplay on mobile devices and online platforms with Virtual Piggy’s financial management solutions that empower youth under 18 to make purchasing, saving, and other money management decisions within boundaries designated by parents.
“We are delighted to partner with Virtual Piggy,” David Lord, CEO at JumpStart stated in the press release. “The safety and control features for the under 18 gamer make them a key partner for JumpStart.”
JumpStart has released best-selling mobile games that include JumpStart® Pet Rescue, JumpStart® Preschool Magic of Learning, as well as educational games such as the award-winning Math Blaster®.
“JumpStart’s strong following of over 30 million parents coupled with popular games that are both well recognized under the DreamWorks Brand and educational field make them a great addition to the Virtual Piggy gaming portfolio,” said Virtual Piggy founder and CEO, Dr. Jo Webber.
For information, visit www.VirtualPiggy.com or www.JumpStart.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The partnership will leverage JumpStart’s technology that allows for simultaneous, real-time gameplay on mobile devices and online platforms with Virtual Piggy’s financial management solutions that empower youth under 18 to make purchasing, saving, and other money management decisions within boundaries designated by parents.
“We are delighted to partner with Virtual Piggy,” David Lord, CEO at JumpStart stated in the press release. “The safety and control features for the under 18 gamer make them a key partner for JumpStart.”
JumpStart has released best-selling mobile games that include JumpStart® Pet Rescue, JumpStart® Preschool Magic of Learning, as well as educational games such as the award-winning Math Blaster®.
“JumpStart’s strong following of over 30 million parents coupled with popular games that are both well recognized under the DreamWorks Brand and educational field make them a great addition to the Virtual Piggy gaming portfolio,” said Virtual Piggy founder and CEO, Dr. Jo Webber.
For information, visit www.VirtualPiggy.com or www.JumpStart.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cardium Therapeutics, Inc. (CXM) Reports Favorable Recommendations from ISS and Glass Lewis for Upcoming Proposals
Today before the opening bell, Cardium Therapeutics announced that Institutional Shareholder Services, Inc. (“ISS”) and Glass, Lewis & Co., LLC (“Glass Lewis”), the nation’s leading independent proxy advisory firms, each recommend that Cardium’s stockholders vote “FOR” all proposals in the proxy statement and recommends a “1 Year” advisory say on pay frequency with respect to the matters that will be considered at the company’s annual meeting scheduled for June 6, 2013.
“We are pleased that Glass Lewis and ISS, the leading independent proxy and corporate governance advisory firms whose recommendations are relied upon by institutional shareholders, have recommended in favor of all proposals contained in our recent proxy statement. Each of these firms recommend a vote “For” the following: (1) re-election our Class I Directors, Edward W. Gabrielson, M.D. and Lon E. Otremba; (2) approval of the compensation paid to our named executive officers; (3) approval of the sale of the Series A Convertible Preferred Stock; (4) approval of a reverse stock split (5) approval of an increase to authorized common stock; and (6) ratification of the selection of our independent auditors. Our Board of Directors encourages all stockholders to submit their proxies in support of the Company’s proposals,” stated Christopher J. Reinhard, Cardium’s Chairman and CEO.
Cardium’s proxy statement and any other materials filed by the company with the SEC can be obtained at the SEC’s website at www.sec.gov or from www.cardiumthx.com. Only stockholders who held the company’s common stock as of the record date of April 26, 2013 are eligible to vote at the annual meeting. As always, the proxy statement should be read carefully before making any voting decision.
Those who have questions about the upcoming, voting methods, or proxy materials should contact Cardium’s proxy advisor, Georgeson, at 888-219-832.
For more information, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are pleased that Glass Lewis and ISS, the leading independent proxy and corporate governance advisory firms whose recommendations are relied upon by institutional shareholders, have recommended in favor of all proposals contained in our recent proxy statement. Each of these firms recommend a vote “For” the following: (1) re-election our Class I Directors, Edward W. Gabrielson, M.D. and Lon E. Otremba; (2) approval of the compensation paid to our named executive officers; (3) approval of the sale of the Series A Convertible Preferred Stock; (4) approval of a reverse stock split (5) approval of an increase to authorized common stock; and (6) ratification of the selection of our independent auditors. Our Board of Directors encourages all stockholders to submit their proxies in support of the Company’s proposals,” stated Christopher J. Reinhard, Cardium’s Chairman and CEO.
Cardium’s proxy statement and any other materials filed by the company with the SEC can be obtained at the SEC’s website at www.sec.gov or from www.cardiumthx.com. Only stockholders who held the company’s common stock as of the record date of April 26, 2013 are eligible to vote at the annual meeting. As always, the proxy statement should be read carefully before making any voting decision.
Those who have questions about the upcoming, voting methods, or proxy materials should contact Cardium’s proxy advisor, Georgeson, at 888-219-832.
For more information, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The Case for PITOOEY! Inc. (PTOO)
PITOOEY! Inc., a new digital marketing company expanding to encompass a nationwide network of localized markets, is all about linking companies and consumers in a more effective consumer-driven way than existing services.
The company’s PITOOEY! app is a preference and location based searchable ad network that lets consumers “pull” offers based upon their unique interests, current location, previous purchases, and other data, while providing businesses with a different and powerful engagement tool. It’s an approach designed to transform the nature of mobile search by delivering dynamic results to users based upon a preference list they create themselves, automatically keeping them informed of the hottest deals and helping them find local deals and dealers depending upon where the user is located and other parameters. As such, it frees consumers of a major complaint: having to sift through piles of irrelevant offers.
From an investment standpoint, PITOOEY! Inc. represents a new consumer-oriented approach, already generating interest in its early stages, with a number of advantages:
• Next-generation technology, driven by a proprietary platform
• Synergistic business model, with numerous expansion opportunities
• Experienced technical and marketing team
• Minimal CapEx and working capital requirements
• Number of mobile app downloads expected to reach 108 billion by 2017
• Global mobile payments expected to reach $618 billion by 2016
• Ongoing and rapid shift of consumers to purchases through mobile devices
• Growing demand by consumers for more customized/localized online purchasing information
PITOOEY! gives the consumer the powerful search capabilities of Google, together with the focused consumer targeting and sharing of Facebook, the content customization of iTunes, and the localized retail offers of Groupon, all via easy-to-get, easy-to-use, and easy-to-share short messages. Message contact is “pulled” by the consumer, not “pushed” by the business, offering content of far greater relevance and end value to the user.
The PITOOEY! consumer-driven app is part of the company’s larger integrated digital media platform that includes Choice One Mobile, Rockstar Digital, Mobile Caviar, and Go Mobile For A Buck.
For more information, see the company website at www.PITOOEY.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company’s PITOOEY! app is a preference and location based searchable ad network that lets consumers “pull” offers based upon their unique interests, current location, previous purchases, and other data, while providing businesses with a different and powerful engagement tool. It’s an approach designed to transform the nature of mobile search by delivering dynamic results to users based upon a preference list they create themselves, automatically keeping them informed of the hottest deals and helping them find local deals and dealers depending upon where the user is located and other parameters. As such, it frees consumers of a major complaint: having to sift through piles of irrelevant offers.
From an investment standpoint, PITOOEY! Inc. represents a new consumer-oriented approach, already generating interest in its early stages, with a number of advantages:
• Next-generation technology, driven by a proprietary platform
• Synergistic business model, with numerous expansion opportunities
• Experienced technical and marketing team
• Minimal CapEx and working capital requirements
• Number of mobile app downloads expected to reach 108 billion by 2017
• Global mobile payments expected to reach $618 billion by 2016
• Ongoing and rapid shift of consumers to purchases through mobile devices
• Growing demand by consumers for more customized/localized online purchasing information
PITOOEY! gives the consumer the powerful search capabilities of Google, together with the focused consumer targeting and sharing of Facebook, the content customization of iTunes, and the localized retail offers of Groupon, all via easy-to-get, easy-to-use, and easy-to-share short messages. Message contact is “pulled” by the consumer, not “pushed” by the business, offering content of far greater relevance and end value to the user.
The PITOOEY! consumer-driven app is part of the company’s larger integrated digital media platform that includes Choice One Mobile, Rockstar Digital, Mobile Caviar, and Go Mobile For A Buck.
For more information, see the company website at www.PITOOEY.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, May 24, 2013
Shin Nagakura Joins PFSweb, Inc. (PFSW) Board of Directors
International provider of end-to-end eCommerce solutions, PFSweb announced the appointment of Shin Nagakura to its Board of Directors. Non-employee Director Timothy W. Murray is set to retire from the board effective immediately.
Nagakura is currently Director of transcosmos inc. (TSE: 9715) (“TCI”), a leading Japanese business process-outsourcing firm. His appointment will fulfill a condition of the strategic relationship that PFSweb and TCI entered into on May 15, 2013, which states that a TCI representative will sit on PFSweb’s Board.
“Adding Mr. Nagakura to the Board is an important step in building and maximizing our relationship with transcosmos,” commented Mike Willoughby, CEO of PFSweb. “His presence will help us execute on our goal to become a truly global end-to-end multi-channel eCommerce service provider. By combining our iCommerce solution with TCI’s market capabilities, we will not only create opportunities for PFSweb clients to enter the fast-growing Asian market, but also drive revenue growth by providing eCommerce services for Asian companies looking to expand into the U.S and Europe.”
Nagakura brings over 15 years of experience investing in and advising technology companies to TCI’s Silicon Valley office. His resume includes companies such as RealNetworks, Brightcove, and AskJeeves. Most recently Nagakura held a position for ten years at Recruit Co. Ltd., a marketing services, internet media, and publishing company. Additionally Nagakura serves on the Board of Directors of Merlin Information Systems, Ltd., and Become, Inc., a leader in e-commerce and online comparison-shopping. He graduated from Sophia University in Tokyo with a B.A. in International Studies in 1986.
PFSweb is currently engaged by iconic brands to help enable and manage customized eCommerce initiatives. To learn more about PFSweb, please visit: www.PFSweb.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Nagakura is currently Director of transcosmos inc. (TSE: 9715) (“TCI”), a leading Japanese business process-outsourcing firm. His appointment will fulfill a condition of the strategic relationship that PFSweb and TCI entered into on May 15, 2013, which states that a TCI representative will sit on PFSweb’s Board.
“Adding Mr. Nagakura to the Board is an important step in building and maximizing our relationship with transcosmos,” commented Mike Willoughby, CEO of PFSweb. “His presence will help us execute on our goal to become a truly global end-to-end multi-channel eCommerce service provider. By combining our iCommerce solution with TCI’s market capabilities, we will not only create opportunities for PFSweb clients to enter the fast-growing Asian market, but also drive revenue growth by providing eCommerce services for Asian companies looking to expand into the U.S and Europe.”
Nagakura brings over 15 years of experience investing in and advising technology companies to TCI’s Silicon Valley office. His resume includes companies such as RealNetworks, Brightcove, and AskJeeves. Most recently Nagakura held a position for ten years at Recruit Co. Ltd., a marketing services, internet media, and publishing company. Additionally Nagakura serves on the Board of Directors of Merlin Information Systems, Ltd., and Become, Inc., a leader in e-commerce and online comparison-shopping. He graduated from Sophia University in Tokyo with a B.A. in International Studies in 1986.
PFSweb is currently engaged by iconic brands to help enable and manage customized eCommerce initiatives. To learn more about PFSweb, please visit: www.PFSweb.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
East Meets West in SoHo this Summer with PacSun’s (PSUN) New Pop-Up Retail Concept
Pacific Sunwear of California is bringing the West Coast to the East Coast this summer with its brand new pop-up retail concept.
On May 24, 2013, PacSun unveiled its new pop-up shop at 583 Broadway, located in New York’s SoHo district. The pop-up shop will be open from Memorial weekend through Labor Day, featuring the apparel retailer’s most prominent men’s and women’s brands in new and creative ways. Throughout the summer, the pop-up shop will host special events, beginning with live, in-store DJ performances from May 25-27 as part of its grand opening activities this coming weekend.
“We are excited about opening our first-ever pop-up store right in the heart of SoHo on Broadway in lower Manhattan,” said PacSun CEO Gary Schoenfeld. “Our primary objective is to bring the best of PacSun and showcase the best of our industry at one of the world’s most influential fashion and shopping destinations.”
At more than 10,000 square feet, the dual-level store greatly surpasses PacSun’s usual footprint and includes expansive selling space and distinct merchandising assortments that will showcase many of the company’s key branded partners, including Nike, Hurley, Vans, Diamond Supply Co., Modern Amusement, Beats by Dr. Dre, Brandy Melville, and PacSun’s exclusive collaboration with Kendall & Kylie Jenner.
The pop-up retail space boasts a custom design, fusing New York City Elements with PacSun’s California roots and “Golden State of Mind” brand essence. Upon entering the space, shoppers will be transported to a place where brands and fashion are a celebrated experience, in an atmosphere where Death Valley meets New York skylines. An edited array of additional brands will also be featured, including RVCA, Volcom, Crooks & Castles, Neff, Young & Restless, Us Versus Them, Stance, Rook Billabong, Roxy and Bullhead Denim Co. The men’s and women’s departments will each feature a shop that houses new and exclusive brand offerings, which will rotate every two weeks.
For more information about PacSun and its new New York pop-up shop, visit www.PacSun.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
On May 24, 2013, PacSun unveiled its new pop-up shop at 583 Broadway, located in New York’s SoHo district. The pop-up shop will be open from Memorial weekend through Labor Day, featuring the apparel retailer’s most prominent men’s and women’s brands in new and creative ways. Throughout the summer, the pop-up shop will host special events, beginning with live, in-store DJ performances from May 25-27 as part of its grand opening activities this coming weekend.
“We are excited about opening our first-ever pop-up store right in the heart of SoHo on Broadway in lower Manhattan,” said PacSun CEO Gary Schoenfeld. “Our primary objective is to bring the best of PacSun and showcase the best of our industry at one of the world’s most influential fashion and shopping destinations.”
At more than 10,000 square feet, the dual-level store greatly surpasses PacSun’s usual footprint and includes expansive selling space and distinct merchandising assortments that will showcase many of the company’s key branded partners, including Nike, Hurley, Vans, Diamond Supply Co., Modern Amusement, Beats by Dr. Dre, Brandy Melville, and PacSun’s exclusive collaboration with Kendall & Kylie Jenner.
The pop-up retail space boasts a custom design, fusing New York City Elements with PacSun’s California roots and “Golden State of Mind” brand essence. Upon entering the space, shoppers will be transported to a place where brands and fashion are a celebrated experience, in an atmosphere where Death Valley meets New York skylines. An edited array of additional brands will also be featured, including RVCA, Volcom, Crooks & Castles, Neff, Young & Restless, Us Versus Them, Stance, Rook Billabong, Roxy and Bullhead Denim Co. The men’s and women’s departments will each feature a shop that houses new and exclusive brand offerings, which will rotate every two weeks.
For more information about PacSun and its new New York pop-up shop, visit www.PacSun.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Hastings Entertainment, Inc. (HAST) to Host Annual Scholarship Golf Tournament on May 30th
Leading multimedia superstore retailer, Hastings Entertainment announced today that its 24th annual Madge Marmaduke Scholarship Golf Tournament will be held on Thursday, May 30, 2013, at the Ross Rogers Golf Club in Amarillo, Texas. 212 golfers, all of whom have donated to the scholarship fund, are expected to compete.
All proceeds from the golf tournament benefit the scholarship fund, which provides tuition assistance to hardworking employees and their family members whose academic performance points to continued success. Candidates are evaluated not only based on academic records and test scores, but also extracurricular activities, volunteer work, work history, ability to communicate, recommendations, and financial need. Since its commencement in 1990, the Madge Marmaduke Scholarship Fund has awarded 175 four-year scholarships totaling over $1,000,000.
Hastings Entertainment currently operates 134 stores and three concept stores: Sun Adventure Sports in both Amarillo and Lubbock, Texas, and TRADESMART in Littleton, Colorado. Hastings offers new and used books, videos, video games, and CDs, as well as trends and consumer electronics merchandise. The company also runs www.goHastings.com, an e-commerce website that makes offers new and used entertainment products and unique, contemporary gifts and toys.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
All proceeds from the golf tournament benefit the scholarship fund, which provides tuition assistance to hardworking employees and their family members whose academic performance points to continued success. Candidates are evaluated not only based on academic records and test scores, but also extracurricular activities, volunteer work, work history, ability to communicate, recommendations, and financial need. Since its commencement in 1990, the Madge Marmaduke Scholarship Fund has awarded 175 four-year scholarships totaling over $1,000,000.
Hastings Entertainment currently operates 134 stores and three concept stores: Sun Adventure Sports in both Amarillo and Lubbock, Texas, and TRADESMART in Littleton, Colorado. Hastings offers new and used books, videos, video games, and CDs, as well as trends and consumer electronics merchandise. The company also runs www.goHastings.com, an e-commerce website that makes offers new and used entertainment products and unique, contemporary gifts and toys.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
LiveDeal, Inc. (LIVE) Subsidiary Selected by San Diego Paralegal Association for Web, Social Media, and Mobile Marketing
LiveDeal, a provider of marketing solutions that boost customer awareness and merchant visibility on the Internet, yesterday announced that Velocity Local, its wholly-owned subsidiary, was recently selected by the San Diego Paralegal Association (SDPA) to provide all of its web, social media, and mobile marketing services. The recent launch of the SDPA’s full-featured website is key to this new campaign: the website is complete with membership information, a dynamic events calendar, online access to member newsletters, a job bank, paralegal resources, and downloadable forms.
“We needed to deliver a comprehensive networking and professional development environment to our members,” commented Heidi Mares, ACP as Director of Public Relations at SDPA. “Velocity Local was instrumental in helping us achieve that goal with their straightforward and cost-efficient managed service platform complete with mobile accessibility and professional social media engagement. Our top priority is our members and the board feels that this new image and connection will show that SDPA cares.”
A non-profit organization, SDPA connects with the legal profession through educating, promoting, and strengthening. LiveDeal has confirmed that Velocity Local will help advance the organization’s mission by seamlessly managing its internet marketing efforts while simultaneously extending SDPA’s capabilities with creative web designers, social media strategists, copywriters, and app programmers. Velocity Local will dedicate one project manager to orchestrate each function.
SDPA is currently developing a mobile app which will provide its members with Google mapping to hosted events, click-to-call access to member services, and social media integration. Velocity Local plans to further introduce and administer the organization’s social media network including its Facebook (FB), Twitter, Google Plus, and LinkedIn presence.
“We’re thrilled to be the provider of choice for SDPA’s evolving Internet marketing needs,” said Vanessa Luna, Director of Business Development at Velocity Local. “The new unified campaign is designed to enhance member connectivity, knowledge sharing, and professional networking.”
For more information on Velocity Local, visit www.velocitylocal.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We needed to deliver a comprehensive networking and professional development environment to our members,” commented Heidi Mares, ACP as Director of Public Relations at SDPA. “Velocity Local was instrumental in helping us achieve that goal with their straightforward and cost-efficient managed service platform complete with mobile accessibility and professional social media engagement. Our top priority is our members and the board feels that this new image and connection will show that SDPA cares.”
A non-profit organization, SDPA connects with the legal profession through educating, promoting, and strengthening. LiveDeal has confirmed that Velocity Local will help advance the organization’s mission by seamlessly managing its internet marketing efforts while simultaneously extending SDPA’s capabilities with creative web designers, social media strategists, copywriters, and app programmers. Velocity Local will dedicate one project manager to orchestrate each function.
SDPA is currently developing a mobile app which will provide its members with Google mapping to hosted events, click-to-call access to member services, and social media integration. Velocity Local plans to further introduce and administer the organization’s social media network including its Facebook (FB), Twitter, Google Plus, and LinkedIn presence.
“We’re thrilled to be the provider of choice for SDPA’s evolving Internet marketing needs,” said Vanessa Luna, Director of Business Development at Velocity Local. “The new unified campaign is designed to enhance member connectivity, knowledge sharing, and professional networking.”
For more information on Velocity Local, visit www.velocitylocal.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Meru Networks (MEG) Education-Grade Wireless Solution Featuring Identity Manager Chosen by Cologne Business School
Meru Networks, a market leader in the development of mobile access and virtualized Wi-Fi solutions, announced that the Cologne Business School (CBS) has chosen to deploy a campus wide Meru Education-Grade (MEG™) Wi-Fi network in an effort to address a continuing increase in device density and network traffic on campus. The new network will feature Identity Manager, Meru’s industry-leading guest access solution.
“With the Meru WLAN system we have installed a solution that really meets our needs — particularly with regard to heterogeneity and user density,” said Guido Lokietek, head of the IT department at CBS. “As a result of the faster distribution of new policies, network management has also become easier. In addition, the monitoring feature provides us with a detailed insight into the wireless network load by means of information such as throughput and number of users.”
Currently supported by system integrator AXIANS, CBS was seeking a new wireless system to replace its existing system, which had begun to produce congestion and slow transmission speeds due to technical limitations. The IT department at CBS staged a test to determine the optimum platform for its next wireless network. The test consisted of 80 people in the college’s largest auditorium downloading a two gigabyte file on their end devices at the same time. The test concluded that the MEG WLAN platform from Meru was the best solution.
Visitors to CBS also benefit from the new wireless solution, as Meru’s Identity Manager Guest Connect guest access solution enables quick and easy onboarding for them and their devices. The feature also allows IT staff to focus on other items, as guest access no longer has to be manually set up via Microsoft Active Directory.
Meru’s MEG platform is designed to solve colleges’ and universities’ BYOD issues and support their uninterrupted learning applications.
“Innovative colleges and universities such as Cologne Business School are increasingly looking to Meru’s MEG platform to help them address device density and traffic growth,” said Sarosh Vesuna, vice president and general manager of the education business unit at Meru. “Wi-Fi capacity challenges have become extremely common in higher education, and we continue to optimize our offering to help universities address them.”
For further information, visit www.merunetworks.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“With the Meru WLAN system we have installed a solution that really meets our needs — particularly with regard to heterogeneity and user density,” said Guido Lokietek, head of the IT department at CBS. “As a result of the faster distribution of new policies, network management has also become easier. In addition, the monitoring feature provides us with a detailed insight into the wireless network load by means of information such as throughput and number of users.”
Currently supported by system integrator AXIANS, CBS was seeking a new wireless system to replace its existing system, which had begun to produce congestion and slow transmission speeds due to technical limitations. The IT department at CBS staged a test to determine the optimum platform for its next wireless network. The test consisted of 80 people in the college’s largest auditorium downloading a two gigabyte file on their end devices at the same time. The test concluded that the MEG WLAN platform from Meru was the best solution.
Visitors to CBS also benefit from the new wireless solution, as Meru’s Identity Manager Guest Connect guest access solution enables quick and easy onboarding for them and their devices. The feature also allows IT staff to focus on other items, as guest access no longer has to be manually set up via Microsoft Active Directory.
Meru’s MEG platform is designed to solve colleges’ and universities’ BYOD issues and support their uninterrupted learning applications.
“Innovative colleges and universities such as Cologne Business School are increasingly looking to Meru’s MEG platform to help them address device density and traffic growth,” said Sarosh Vesuna, vice president and general manager of the education business unit at Meru. “Wi-Fi capacity challenges have become extremely common in higher education, and we continue to optimize our offering to help universities address them.”
For further information, visit www.merunetworks.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, May 23, 2013
Rare Element Resources Ltd. (REE) Cleared For NEPA Process by USFS at Bear Lodge Critical Rare Earth Project in Wyoming
Rare Element Resources, which was essentially formed to develop the Bear Lodge Critical Rare Earth Project, reported today that the company has now secured proper notice from the U.S. Forest Service that their plan of operations for the project passes muster for NEPA process (impact and mitigation analysis) formal proceedings to begin.
Extensive USGS data has confirmed estimates of the Bear Lodge site potential, making it one of the biggest deposits of disseminated rare-earth elements in all of North America and there is some good gold and copper mineralization here as well. The plan of operations provides a comprehensive blueprint outlining affected areas and the anticipated environmental protection requirements, in addition to a detail run-down of the proposed operations and the plan will be available on the Rare Element Resources website as early as this June 1.
COO of REE, Jaye Pickarts, happily noted that today’s announcement clears the way for the next phase of development at Bear Lodge and made sure to thank the Bear Lodge District Forest Service, as well as U.S. Forest Service officials (whose job it is to ensure NEPA process compliance), for their efforts in carefully reviewing the proposed plan. The plan packs in all of the laborious environmental/engineering work done thus far on Bear Lodge and REE is set up really nicely here for the upcoming EIS (environmental impact statement), which will form a major part of the NEPA process.
Pickarts pledged that REE will continue to fully support the NEPA process moving forward with all the technical help they are able to assemble and he then doubled-down on REE’s commitment to assisting Forest Service personnel, as well as other state and federal agencies as the project advances.
President and CEO of REE, Randall Scott, called today’s announcement a major environmental and project milestone, tipping his hat to investors about how fortunate REE is to have a lock on this exceptional resource site in the mining-friendly state of Wyoming. Scott pointed to superb logistics, existing infrastructure, and the rich pool of talented personnel available in northeast Wyoming as positive leading indicators of developmental success, underscoring the diligent engagement of state officials, business leaders, and area residents by the company, all of whom Scott was confident understood the vast benefits of properly executed natural resource development like this.
Bear Lodge has a bunch of the critical rare earths we need to fuel the domestic economy in coming decades and with the global market supply for rare earths increasingly scarce, as more hands chase fewer inputs, the project is also of strategic importance for the U.S. economy as a whole. Electronics of every sort, fiber optics, hybrid cars, solar panels, and a variety of other high-tech applications are generating unprecedented global demand for rare earths, especially the rarer kinds available in abundance at Bear Lodge and it is reassuring to know that permitting and feasibility are already well underway.
To learn more about Rare Element Resources, visit www.RareElementResources.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
pSivida Corp. (PSDV) President and CEO Discusses ILUVIEN News, Market Insight, and Other Company Information on New Blog
On May 23, 2013, pSivida Corp. published a new blog post on The Chairman’s Blog entitled “Big and Small Picture,” penned by company President and CEO Dr. Paul Ashton. Located at TheChairmansBlog.com, The Chairman’s Blog is an exclusive online media publication offering key executives a platform for sharing insights about their companies and industry trends.
In the newly published blog, Dr. Ashton elaborates on the age-related macular degeneration (AMD) and chronic diabetic macular edema (DME) markets, as well as competitors in the space. He also provides an overview of recent news relating to the company’s ILUVIEN, which is a sustained-release insert that has been approved in Europe for chronic DME. Ashton further explains the company’s profit split with ILUVIEN’s licensee, Alimera Sciences.
In addition to enabling upper-tier management to discuss issues of importance to their stakeholders, shareholders, and other interested parties, TheChairmansBlog.com features articles on such topics as finance, technology, health and energy, which have been contributed by staff and aggregate partners. The site additionally provides updated market trends, news and information.
Headquartered in Watertown, Mass., pSivida Corp. specializes in the development of tiny, sustained-release drug delivery products that are designed to release drugs at a controlled and steady rate over the course of months or years. The company is presently focused on treating chronic diseases of the back of the eye, utilizing Durasert and BioSilicon, its core technology systems. The company also has two FDA-approved products, Vitrasert and Retisert, which are licensed to Bausch & Lomb. pSivida has licensed ILUVIEN for DME to Alimera Sciences, and that product has been granted marketing authorization in Austria, France, Germany, Portugal, Spain, and the United Kingdom.
The company additionally has clinical trials ongoing for the treatment of posterior uveitis and glaucoma and ocular hypertension. Other technologies the company has in development include protein and antibody delivery systems, which are in early clinical stages. For more information, visit www.pSivida.com
To read Dr. Paul Ashton’s full blog post, visit www.TheChairmansBlog.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
CRAiLAR Technologies, Inc. (CRLRF) Joins Sustainable Apparel Coalition in a Movement Towards Sustainability
CRAiLAR Technologies announced that it has joined the Sustainable Apparel Coalition (SAC). The company will use the group’s sustainability measurement tool, the Higg Index, to measure environmental responsibility across its agriculture and manufacturing processes.
“We welcome CRAiLAR to the Coalition, and look forward to their participation in this industry-wide effort in sustainability, ” said Coalition Executive Director Jason Kibbey. “Having CRAiLAR as part of the Coalition…accelerates the change we’re making towards responsible industry actions.”
The Higg Index is an open source, indicator-based tool that allows suppliers, manufacturers, brands, and retailers to evaluate materials, products, facilities, and processes based on environmental and design choices. CRAiLAR will contribute data and resources to support the Higg Index in an effort to make its supply chain decision-making more efficient and environmentally sustainable.
“With the SAC’s leadership position in the apparel and textiles sectors, we are pleased to contribute to a model for how industries can collaborate in making a positive impact on value chain performance,” said Ken Barker, CRAiLAR’s CEO. “CRAiLAR Flax is a natural fiber that can make an immediate and dramatic impact on product sustainability, a priority of SAC members and non-members alike.”
CRAiLAR joins more than 90 global brands, retailers and manufacturers, governments, non-profit environmental organizations, and academic institutions committed to improving supply chain sustainability in the apparel and footwear industries. For more information on SAC, the complete Higg Index, and a full list of members, please visit www.apparelcoalition.org.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
ECOtality, Inc. (ECTY) Unveils Blink HQ Line of EV Chargers
ECOtality yesterday announced that it was unveiling its new line of home electric vehicle (EV) chargers. The Blink HQ family of Level 2 EV chargers will each come bundled with a free membership to the Blink Network as well as a $100 charging credit.
ECOtality is focused on developing and marketing ecologically-friendly energy products, such as its flagship line of Blink products, which allow for electric vehicle charging. The company also develops Minit Charger products that allow for EV charging in industrial environments. ECOtality also maintains two wholly owned and independently operated subsidiaries: Innergy Power and Fuel Cell Store.
The new Blink HQ products, which launch in Summer of 2013, will offer consumers several benefits. Including the aforementioned membership and credit bundle, the Level 2 chargers will allow for EV charging at a rate of four times faster than Level 1 chargers, and the ability to connect the home charger to one of more than 4,000 publicly available charging stations.
Ravi Brar, CEO of ECOtality, said, “Our premiere line of Blink HQ home charging products offer EV drivers exactly what they’ve been asking for: connection to the Blink Network, freedom to charge at home at their convenience and unprecedented value. As EV sales continue their rapid growth, ECOtality is meeting the need for smart, programmable and affordable quick chargers in the home. We see a clear connection between charging at home, at work, while shopping or on the road during a trip. Having Blink HQ home charging products in EV drivers’ homes, bundled with a membership, will help support our growth and generate an annuity base as the number of EV drivers grows.”
For more information, visit www.ecotality.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
ECOtality is focused on developing and marketing ecologically-friendly energy products, such as its flagship line of Blink products, which allow for electric vehicle charging. The company also develops Minit Charger products that allow for EV charging in industrial environments. ECOtality also maintains two wholly owned and independently operated subsidiaries: Innergy Power and Fuel Cell Store.
The new Blink HQ products, which launch in Summer of 2013, will offer consumers several benefits. Including the aforementioned membership and credit bundle, the Level 2 chargers will allow for EV charging at a rate of four times faster than Level 1 chargers, and the ability to connect the home charger to one of more than 4,000 publicly available charging stations.
Ravi Brar, CEO of ECOtality, said, “Our premiere line of Blink HQ home charging products offer EV drivers exactly what they’ve been asking for: connection to the Blink Network, freedom to charge at home at their convenience and unprecedented value. As EV sales continue their rapid growth, ECOtality is meeting the need for smart, programmable and affordable quick chargers in the home. We see a clear connection between charging at home, at work, while shopping or on the road during a trip. Having Blink HQ home charging products in EV drivers’ homes, bundled with a membership, will help support our growth and generate an annuity base as the number of EV drivers grows.”
For more information, visit www.ecotality.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Location Based Technologies, Inc. (LBAS) Receives High Marks from MacReview.com
Location Based Technologies, a provider of GPS tracking devices, has received a 5 star product review for its PocketFinder personal locator from MacReview.com, which publishes a range of product reviews/ratings.
In its review, MacReview highlights the PocketFinder device features and calls the PocketFinder iOS app, “One of the most comprehensive apps of this type we’ve ever seen.”
In addition to voicing its favor of the app’s usability, design, and other features, the review lists several pros of the GPS location device and notes that there are no cons.
“We are extremely proud to receive such high praise from MacReview.com,” Location Based Technologies’ CEO Dave Morse stated in the press release. “LBT has consistently focused on the needs and wants of our customers – consumer and commercial. We believe that our products are the best GPS products in the world as they have been designed to enhance customers’ lives by simplifying the way that they are able to stay connected to the people and things that are important to them.”
LBT’s products and services are applicable to a wide range of businesses, including asset tracking, freight and trucking companies, and in highly mobile situations such as emergency response.
For more information visit: www.pocketfinder.com or www.locationbasedtech.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cardium Therapeutics, Inc. (CXM) Leverages Massive Reach of Academy Medical
Cardium Therapeutics announced earlier this year that it had arranged a distribution venture with Academy Medical for marketing, sale, and distribution of Excellagen, an FDA-cleared advanced gel with the ability to speed up the healing of various wounds. Perhaps the most important aspect of the agreement was the size of the customer base that it represents.
Academy Medical is a certified Veteran Owned Small Business, specializing in the distribution of medical products to Department of Veterans Affairs and Department of Defense hospitals and community-based outpatient clinics. The company is the largest distributor of biologics on the Federal Supply Schedule, and the agreement covers the Veterans Administration (VA) healthcare system and military hospitals.
The VA operates the biggest integrated healthcare system in the country, providing care to over 6 million patients and backed up by a budget of more than $50 billion. Their hospital network of 152 major medical centers and 800 community-based outpatient clinics handles approximately 900,000 inpatient hospital admissions each year, and nearly 80 million outpatient visits. With many of the health issues treated involving some form of wound care, Excellagen’s cost effectiveness, ease of use, and ability to hasten wound healing, make it an ideal match.
Cardium CEO, Christopher Reinhardt, commented on how the agreement fits into Cardium’s overall strategic plan for Excellagen: “As the U.S. healthcare market continues to expand due to the aging population and with the implementation of the Affordable Care Act, simpler-use and more cost-effective medical products like Excellagen have an opportunity to expand and grow within outcomes-oriented healthcare settings. Our agreement with Academy Medical expands Cardium’s tactical access and distribution capabilities for Excellagen as we advance forward with our planned U.S. strategic partnering activities. We are in discussions with potential strategic partners to establish representation, marketing and sales, or co-promotional arrangements along four U.S. vertical wound healing market channels: (1) podiatry, (2) wound care centers, hospitals, and long-term care facilities, (3) government medical service providers; and (4) dermatology.”
For additional information, visit www.CardiumTHX.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Antares Pharma, Inc. (ATRS) Adds Marvin Samson to Board of Directors
Antares Pharma is focused on self-administered parenteral pharmaceutical products and topical gel-based medicines. The company is developing products in conjunction with various partners that will help people deal with rheumatoid arthritis, psoriasis, overactive bladder, menopause, and other medical problems.
The company reported today that Marvin Samson has been elected to its Board of Directors by shareholders at the annual shareholder meeting. He is an expert in injectable manufacturing and delivery systems, which is a big part of Antares Pharma’s business. Samson was formerly the group vice-president – worldwide of Teva Pharmaceutical Industries. He has served as CEO and member of the Board at Sicor and was also a founder and CEO of Elkins-Sinn and Marsam Pharmaceuticals.
Additionally, Samson is the founder and CEO of Samson Medical Technologies, a privately-held company providing hospital and alternative site pharmacists with injectable drug delivery systems and programs. He is also Chairman of the Board of JHP Pharmaceuticals and serves on the Board of Directors of Flynn Pharma, NanoPass Technologies, and Emcure Pharmaceuticals. In the past, he served as Chairman of Endo Pharmaceuticals. Samson also holds five patents pertaining to pharmaceutical manufacturing.
Antares’ management is enthused to have Mr. Samson aboard. The company’s CEO, Paul K. Wotton, Ph.D., said, “His extensive commercial expertise in injectable manufacturing and delivery systems will be invaluable as we launch new products and add to an already exciting pipeline. The company’s chairman, Leonard S. Jacob, M.D., Ph.D., added “His broad expertise in all aspects of our business will be an important asset to us as we prepare to launch OTREXUP early next year.” OTREXUP is a combination product for the delivery of methotrexate using its Medi-Jet technology for the treatment of rheumatoid arthritis.
For further information about Antares Pharma, its technologies, and product pipeline, please visit www.antarespharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, May 22, 2013
VistaGen Therapeutics, Inc. (VSTA) and the Frankenstein Revolution
Some call it the Frankenstein revolution, but the fact is that it heralds what may become one of the most important developments in 21st Century medical science. It’s the use of stem cell technology to build living organisms in the laboratory, paving the way for possible customized biological organ and tissue factories that could someday eliminate the need for donors. No longer science fiction, the technology to produce viable tissues and body parts is already under development.
However, there is side to the science, represented by California biotech company VistaGen Therapeutics, that is separate but no less important than the generation of replacement parts for damaged organs. It’s the creation of living tissues for the testing of drugs, allowing a degree of detailed testing and analysis superior in many ways to traditional animal tests or human trials. It’s a form of testing done right in the lab, observable at the cellular and even molecular level, providing detail unavailable any other way. In addition, it can be done at the earliest stages in drug development, long before committing to the time and expense of formal trials or actual marketing, potentially saving major pharmaceutical companies millions or even billions of dollars.
VistaGen Therapeutics has developed a proprietary pluripotent stem cell technology for use in the discovery, rescue, and development of novel drug candidates. These are drugs that have been shown to be effective, but which had to be shelved late in the game due to heart or liver toxicity, a common problem with new drugs. A pharmaceutical company may have spent a fortune on developing a drug, but it now sits on the shelf, its possible value essentially lost.
Using its Human Clinical Trials in a Test Tube bioassay system, VistaGen can now take such drugs and potentially solve the toxicity issues right in the lab. The company’s strategy is to use their technology to build a pipeline of drug rescue variants, proprietary new small molecule drug candidates, in collaboration with contract drug development service companies. VistaGen plans to have economic participation rights to each and every drug it develops, which should benefit its bottom line as well as its shareholders.
For additional information, visit www.VistaGen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
iBio, Inc. (IBIO) Produces a Vaccine Candidate for the Newly Emerged H7N9 Virus
iBio develops and offers product applications of its proprietary iBioLaunch and iBioModulator platforms. In addition, the company develops select vaccine candidates that have been derived from its iBioLaunch platform. Its technology utilizes transient gene expression in unmodified green plants for the development and production of biologics.
The company announced today the production of a vaccine candidate for the recently emerged H7N9 influenza virus (first appeared in China) by an independent third-party laboratory using its BioLaunch platform. This accomplishment took only 21 days as measured from the initial antigen sequence information to purification of recombinant protein.
iBio’s BioLaunch platform eliminates the need to culture cells under sterile conditions, removes uncertainty about yield consistency for large production volumes, and, subject to regulatory approval, can possibly deliver vaccine doses for emergency use against a pandemic or bio-terrorism threat. The platform has been used successfully before to produce vaccine-quality antigens associated with a range of influenza strains including H7N7, H5N1, H3N2, H1N1, and a variety of influenza B strains.
The company’s iBioLaunch platform is a step ahead of current conventional approaches. It eliminates the months involved in the development and production of regular vaccines for viruses. Patient care now often involves only isolation of patients and supportive care. For further information about iBio and its technologies, please visit www.ibioinc.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)